Connection

JOHN KIRKWOOD to Fibroblast Growth Factor 2

This is a "connection" page, showing publications JOHN KIRKWOOD has written about Fibroblast Growth Factor 2.
Connection Strength

0.447
  1. ECOG phase II trial of graded-dose peginterferon a-2b in patients with metastatic melanoma overexpressing basic fibroblast growth factor (E2602). Clin Cancer Res. 2013 Dec 01; 19(23):6597-604.
    View in: PubMed
    Score: 0.447
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.